These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25785021)

  • 1. The polymorphism (Gln261Arg) of 12-lipoxygenase and cancer risk: a meta-analysis.
    Shan D; Shen K; Zhu J; Feng M; Wu Y; Wan C; Shen Y; Xu L
    Int J Clin Exp Med; 2015; 8(1):488-95. PubMed ID: 25785021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer.
    Prasad VV; Kolli P; Moganti D
    Exp Ther Med; 2011 Mar; 2(2):317-323. PubMed ID: 22977504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
    Dong LM; Zhang XY; Teng H; Li MS; Wang P
    Genet Mol Res; 2014 Nov; 13(4):9976-85. PubMed ID: 25501209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray repair cross-complementing gene 1 Arg399Gln polymorphism and glioma risk among Asians: A meta-analysis based on 2 326 cases and 3 610 controls.
    Zhang L; Qiu Z; Luo J; Shu W
    Neural Regen Res; 2012 Oct; 7(29):2313-9. PubMed ID: 25538755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICAM-1 +469 A/G polymorphism and cancer risk: a meta-analysis involving 9375 subjects.
    Wang Y; Jia L; Shen Y; Guo S; Wan C; Yang T; An J; Chen L; Wang T; Wen F
    Int J Clin Exp Med; 2014; 7(1):84-92. PubMed ID: 24482692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
    Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
    World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
    Saadat M; Ansari-Lari M
    Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Arg399Gln polymorphism in the XRCC1 gene is associated with increased risk of hematological malignancies.
    Du L; Liu Y; Xue P; Song C; Shen J; He Q; Peng Y; Tong X; Tang L; Zhang Y
    Tumour Biol; 2015 Jun; 36(6):4545-54. PubMed ID: 25619474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.
    Guo Y; Zhang X; Tan W; Miao X; Sun T; Zhao D; Lin D
    Pharmacogenet Genomics; 2007 Mar; 17(3):197-205. PubMed ID: 17460548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies.
    Ding DP; He XF; Zhang Y
    Breast Cancer Res Treat; 2011 Aug; 129(1):203-9. PubMed ID: 21424776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
    Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC
    Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A meta-analysis of susceptibility to pneumoconiosis and polymorphism of tumor necrosis factor-α 308 and 238 locus].
    Li J; Hao CF; Yao W; Yun YX; Gao B; Wang YX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jun; 45(6):547-52. PubMed ID: 21914340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arg462Gln and Asp541Glu polymorphisms in ribonuclease L and prostate cancer risk: a meta-analysis.
    Mi Y; Yu Q; Min Z; Xu B; Zhang L; Zhang W; Feng N; Hua L
    J Biomed Res; 2010 Sep; 24(5):365-73. PubMed ID: 23554651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair gene X-ray repair cross complementing group 1 Arg194Trp polymorphism on the risk of lung cancer: a meta-analysis on 22 studies.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z; Zhan Q; Lin H
    J Thorac Oncol; 2010 Nov; 5(11):1741-7. PubMed ID: 20975374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1α -889 C/T polymorphism and cancer susceptibility: a meta-analysis.
    Cheng D; Hao Y; Zhou W
    Onco Targets Ther; 2014; 7():2067-74. PubMed ID: 25419144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of SULT1A1 codon 213 polymorphism and breast cancer susceptibility: meta-analysis from 16 studies involving 23,445 subjects.
    Sun Y; Zang Z; Xu X; Zhang Z; Zhong L; Zan W; Zhao Y; Sun L
    Breast Cancer Res Treat; 2011 Jan; 125(1):215-9. PubMed ID: 20505990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis.
    Wang C; Sun Y; Han R
    Urology; 2008 Oct; 72(4):869-72. PubMed ID: 18336890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Aurora-A V57I Polymorphism and the Risk of Cancer: A Meta-Analysis and Trial Sequential Analysis.
    Chen G; Hu C; Song Y; Xiu M; Zhang Y; Lai P; Li Y; Liu X; Huang P
    J Cancer; 2020; 11(11):3225-3234. PubMed ID: 32231728
    [No Abstract]   [Full Text] [Related]  

  • 20. No Evidence of Association of the Arg72Pro p53 Gene Polymorphism with Cancer Risk in the Saudi Population: a Meta-Analysis.
    Irshad M; Mandal RK; Al-Drees A; Khalil MS; Abdulghani HM
    Asian Pac J Cancer Prev; 2015; 16(14):5663-7. PubMed ID: 26320432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.